Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities

Biol Pharm Bull. 2005 Aug;28(8):1438-43. doi: 10.1248/bpb.28.1438.

Abstract

The anti-allergic and anti-oxidative activities of curcumin-related compounds (glycosides, reductants and bis-demethoxy analogs) were investigated to elucidate the underlying active mechanisms and structural features of curcumin in exerting these activities. The anti-allergic activities were assessed by measurement of histamine release from rat basophilic leukemia cells, RBL-2H3. Curcumin and tetrahydrocurcumin (THC) caused a marked decrease in histamine release. Glycosides of curcumin, bis-demethoxycurcumin and THC also inhibited the release of histamine, though less potently than curcumin did. The anti-oxidative activities were assessed by measurement of cell-free or cellular radical scavenging. All compounds but diglycosides or bis-demethoxycurcumin analogs distinctly exerted anti-oxidative effects. The relationship between both of these activities revealed that all compounds with potent radical scavenging activities caused a definite decrease in histamine release, but some compounds with non-potent radical scavenging activities also inhibited the histamine release. These results suggest that the hydroxy groups of curcumin play a significant role in exerting both the anti-oxidative and anti-allergic activities, and that most of the compounds develop the anti-allergic activities through mechanisms related to anti-oxidative activities, but some through mechanisms unrelated to anti-oxidation activity.

MeSH terms

  • Animals
  • Anti-Allergic Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Calcimycin / pharmacology
  • Cell Line, Tumor
  • Concanavalin A / pharmacology
  • Curcumin / analogs & derivatives
  • Curcumin / pharmacology*
  • Histamine Release / drug effects
  • Rats

Substances

  • Anti-Allergic Agents
  • Antioxidants
  • Concanavalin A
  • Calcimycin
  • Curcumin